Mechanisms of complement lectin pathway activation and resistance by trypanosomatid parasites

Molecular Immunology

Volumn 53, Issue 4, 2013, Pages 328-334

  Cestari, Igor ^a,b   Evans Osses, Ingrid ^b   Schlapbach, Luregn J ^c   de Messias Reason, Iara ^d   Ramirez, Marcel I ^b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c MATER CHILDREN S HOSPITAL   (Australia)

^d FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Chagas disease; Complement system; Innate immunity; Lectin pathway; Parasite host cell interaction; T. cruzi; Trypanosomiasis

Indexed keywords

COMPLEMENT COMPONENT C2; LECTIN; N ACETYLGLUCOSAMINE;

CHAGAS DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENOTYPE; HOST PARASITE INTERACTION; HUMAN; KINETOPLASTIDA; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTOZOON; REVIEW; TRYPANOSOMATID INFECTION; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LECTINS; MANNOSE-BINDING LECTIN; TRYPANOSOMA; TRYPANOSOMIASIS, AFRICAN; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

PROTOZOA; TRYPANOSOMATIDAE;

EID: 84867121977     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.08.015     Document Type: Review

References (65)

1. Alonso D.P., Ferreira A.F., Ribolla P.E., de Miranda Santos I.K., do Socorro Pires e Cruz M., Aecio de Carvalho F., Abatepaulo A.R., Lamounier Costa D., Werneck G.L., Farias T.J., et al. Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. Journal of Infectious Diseases 2007, 195(8):1212-1217.
2. Ambrosio A.R., De Messias-Reason I.J. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunology 2005, 27(9):333-340.
3. Arnold J.N., Wormald M.R., Suter D.M., Radcliffe C.M., Harvey D.J., Dwek R.A., Rudd P.M., Sim R.B. Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. Journal of Biological Chemistry 2005, 280(32):29080-29087.
4. Asgharzadeh M., Mazloumi A., Kafil H.S., Ghazanchaei A. Mannose-binding lectin gene and promoter polymorphism in visceral leishmaniasis caused by Leishmania infantum. Pakistan Journal of Biological Sciences 2007, 10(11):1850-1854.
5. Atkinson A.P., Cedzynski M., Szemraj J., St Swierzko A., Bak-Romaniszyn L., Banasik M., Zeman K., Matsushita M., Turner M.L., Kilpatrick D.C. L-ficolin in children with recurrent respiratory infections. Clinical and Experimental Immunology 2004, 138(3):517-520.
6. Beucher M., Norris K.A. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family. Infection and Immunity 2008, 76(2):750-758.
7. Beucher M., Meira W.S., Zegarra V., Galvao L.M., Chiari E., Norris K.A. Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein. Protein Expression and Purification 2003, 27(1):19-26.
8. Boldt A.B., Luz P.R., Messias-Reason I.J. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clinical Immunology 2011, 140(1):63-70.
9. Brittingham A., Morrison C.J., McMaster W.R., McGwire B.S., Chang K.P., Mosser D.M. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. Journal of Immunology 1995, 155(6):3102-3111.
10. Buscaglia C.A., Campo V.A., Frasch A.C., Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nature Reviews Microbiology 2006, 4(3):229-236.
11. Cedzynski M., Atkinson A.P., St Swierzko A., MacDonald S.L., Szala A., Zeman K., Buczylko K., Bak-Romaniszyn L., Wiszniewska M., Matsushita M., et al. L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Molecular Immunology 2009, 47(2-3):415-419.
12. Cestari I., Ramirez M.I. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PLoS ONE 2010, 5:e9721.
13. Cestari I., Evans-Osses I., Freitas J.C., Inal J.M., Ramirez M.I. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. Journal of Infectious Diseases 2008, 198(9):1276-1283.
14. Cestari I., Krarup A., Sim R.B., Inal J.M., Ramirez M.I. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Molecular Immunology 2009, 47(2-3):426-437.
15. Cestari I., Ansa-Addo E., Deolindo P., Inal J.M., Ramirez M.I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. Journal of Immunology 2012, 188(4):1942-1952.
16. Dominguez M., Moreno I., Lopez-Trascasa M., Torano A. Complement interaction with trypanosomatid promastigotes in normal human serum. Journal of Experimental Medicine 2002, 195(4):451-459.
17. Engstler M., Pfohl T., Herminghaus S., Boshart M., Wiegertjes G., Heddergott N., Overath P. Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 2007, 131(3):505-515.
18. Evans-Osses I., Ansa-Addo E.A., Inal J.M., Ramirez M.I. Involvement of lectin pathway activation in the complement killing of Giardia intestinalis. Biochemical and Biophysical Research Communications 2010, 395(3):382-386.
19. Ferreira V., Molina M.C., Valck C., Rojas A., Aguilar L., Ramirez G., Schwaeble W., Ferreira A. Role of calreticulin from parasites in its interaction with vertebrate hosts. Molecular Immunology 2004, 40(17):1279-1291.
20. Ferreira V., Valck C., Sanchez G., Gingras A., Tzima S., Molina M.C., Sim R., Schwaeble W., Ferreira A. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. Journal of Immunology 2004, 172(5):3042-3050.
21. Fischer E., Ouaissi M.A., Velge P., Cornette J. Kazatchkine MD: gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology 1988, 65(2):299-303.
22. Frevert U., Schenkman S., Nussenzweig V. Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infection and Immunity 1992, 60(6):2349-2360.
23. Garlatti V., Belloy N., Martin L., Lacroix M., Matsushita M., Endo Y., Fujita T., Fontecilla-Camps J.C., Arlaud G.J., Thielens N.M., et al. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO Journal 2007, 26(2):623-633.
24. Green P.J., Feizi T., Stoll M.S., Thiel S., Prescott A., McConville M.J. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Molecular and Biochemical Parasitology 1994, 66(2):319-328.
25. Holmberg V., Schuster F., Dietz E., Sagarriga Visconti J.C., Anemana S.D., Bienzle U., Mockenhaupt F.P. Mannose-binding lectin variant associated with severe malaria in young African children. Microbes and Infection 2008, 10(4):342-348.
26. Hourcade D.E., Mitchell L.M., Medof M.E. Decay acceleration of the complement alternative pathway C3 convertase. Immunopharmacology 1999, 42(1-3):167-173.
27. Inal J.M., Schifferli J.A. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2. Journal of Immunology 2002, 168(10):5213-5221.
28. Inal J.M., Hui K.M., Miot S., Lange S., Ramirez M.I., Schneider B., Krueger G., Schifferli J.A. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. Journal of Immunology 2005, 174(1):356-366.
29. Joiner K., Sher A., Gaither T., Hammer C. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proceedings of the National Academy of Sciences of the United States of America 1986, 83(17):6593-6597.
30. Krarup A., Mitchell D.A., Sim R.B. Recognition of acetylated oligosaccharides by human L-ficolin. Immunology Letters 2008, 118(2):152-156.
31. Kuttner-Kondo L.A., Dybvig M.P., Mitchell L.M., Muqim N., Atkinson J.P., Medof M.E., Hourcade D.E. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. Journal of Biological Chemistry 2003, 278(52):52386-52391.
32. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nature Reviews Microbiology 2008, 6(2):132-142.
33. Luz P.R., Miyazaki M.I., Neto N.C., Nisihara R.M., Messias-Reason I.J. High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas Disease. International Journal of Cardiology 2010, 143(3):448-450.
34. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine 1995, 1(3):237-243.
35. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. Journal of Experimental Medicine 1992, 176(6):1497-1502.
36. Matsushita M., Fujita T. Ficolins and the lectin complement pathway. Immunological Reviews 2001, 180:78-85.
37. Matsushita M., Endo Y., Fujita T. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. Journal of Immunology 2000, 164(5):2281-2284.
38. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). Journal of Immunology 2002, 168(7):3502-3506.
39. Moreno I., Molina R., Torano A., Laurin E., Garcia E., Dominguez M. Comparative real-time kinetic analysis of human complement killing of Leishmania infantum promastigotes derived from axenic culture or from Phlebotomus perniciosus. Microbes and Infection 2007, 9(14-15):1574-1580.
40. Munthe-Fog L., Hummelshoj T., Honore C., Madsen H.O., Permin H., Garred P. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. New England Journal of Medicine 2009, 360(25):2637-2644.
41. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infection and Immunity 1998, 66(6):2460-2465.
42. Norris K.A., Harth G., So M. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. Infection and Immunity 1989, 57(8):2372-2377.
43. Norris K.A., Bradt B., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. Journal of Immunology 1991, 147(7):2240-2247.
44. Pangburn M.K., Muller-Eberhard H.J. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3. Annals of the New York Academy of Sciences 1983, 421:291-298.
45. Puentes S.M., Da Silva R.P., Sacks D.L., Hammer C.H., Joiner K.A. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. Journal of Immunology 1990, 145(12):4311-4316.
46. Ramirez G., Valck C., Molina M.C., Ribeiro C.H., Lopez N., Sanchez G., Ferreira V.P., Billetta R., Aguilar L., Maldonado I., et al. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 2011, 216(1-2):265-273.
47. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. Journal of Immunology 2001, 167(5):2861-2868.
48. Rudenko G. African trypanosomes: the genome and adaptations for immune evasion. Essays in Biochemistry 2011, 51(2011):47-62.
49. Runza V.L., Schwaeble W., Mannel D.N. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008, 213(3-4):297-306.
50. Russell D.G. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. European Journal of Biochemistry 1987, 164(1):213-221.
51. Russo D.C., Williams D.J., Grab D.J. Mechanisms for the elimination of potentially lytic complement-fixing variable surface glycoprotein antibody-complexes in Trypanosoma brucei. Parasitology Research 1994, 80(6):487-492.
52. Santos I.K., Costa C.H., Krieger H., Feitosa M.F., Zurakowski D., Fardin B., Gomes R.B., Weiner D.L., Harn D.A., Ezekowitz R.A., et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infection and Immunity 2001, 69(8):5212-5215.
53. Schlapbach L.J., Thiel S., Kessler U., Ammann R.A., Aebi C., Jensenius J.C. Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut 2010, 60(10):1438-1439.
54. Schlapbach L.J., Mattmann M., Thiel S., Boillat C., Otth M., Nelle M., Wagner B., Jensenius J.C., Aebi C. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clinical Infectious Diseases 2010, 51(2):153-162.
55. Spath G.F., Epstein L., Leader B., Singer S.M., Avila H.A., Turco S.J., Beverley S.M. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(16):9258-9263.
56. Spath G.F., Garraway L.A., Turco S.J., Beverley S.M. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(16):9536-9541.
57. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C., Schwaeble W.J. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. Journal of Immunology 1999, 162(6):3481-3490.
58. Stover C.M., Lynch N.J., Hanson S.J., Windbichler M., Gregory S.G., Schwaeble W.J. Organization of the MASP2 locus and its expression profile in mouse and rat. Mammalian Genome 2004, 15(11):887-900.
59. Takahashi M., Endo Y., Fujita T., Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. International Immunology 1999, 11(5):859-863.
60. Tambourgi D.V., Kipnis T.L., da Silva W.D., Joiner K.A., Sher A., Heath S., Hall B.F., Ogden G.B. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infection and Immunity 1993, 61(9):3656-3663.
61. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997, 386(6624):506-510.
62. Valck C., Ramirez G., Lopez N., Ribeiro C.H., Maldonado I., Sanchez G., Ferreira V.P., Schwaeble W., Ferreira A. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Molecular Immunology 2010, 47(7-8):1516-1521.
63. Vorup-Jensen T., Petersen S.V., Hansen A.G., Poulsen K., Schwaeble W., Sim R.B., Reid K.B., Davis S.J., Thiel S., Jensenius J.C. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. Journal of Immunology 2000, 165(4):2093-2100.
64. Weis W.I., Drickamer K., Hendrickson W.A. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992, 360(6400):127-134.
65. WHO: http://wwwwhoint/en/2011.